Home › Hidradenitis Suppurativa › Indiana
Hidradenitis Suppurativa clinical trials in Indiana
7 studies for Hidradenitis Suppurativa are looking for participants at sites in Indiana.
Cities in Indiana
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US108, Indianapolis
- Investigative Site US008, Indianapolis
- Investigative Site US064, West Lafayette
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Southern IN Clinical Trials, New Albany
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 9, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Plainfield
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Oct 29, 2026 · NCT07783542A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 101, Indianapolis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Deaconess Clinic - Downtown Fourth Street- Site Number : 8400029, Evansville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 9, West Lafayette
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07828860Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Options Research Group, Llc, West Lafayette
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 9, 2026 · NCT07049575From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.